Antonio Tito

SOMOS is changing and democratizing new health solutions for Latin American populations. With their database generation (bio banking), Latinx population genomics (ancestry) algorithms, and data analysis, they are creating the first platform for genetic target identification, that will derive in high specificity drug discovery in one of the most underrepresented groups worldwide.